Riskpilot← Back to searchSign inGet full accessHemfosa NYAB 18 AB
ABDissolvedOrg 5591685994Economic activity was not specified by tax authority · NACE 0000Est. 20180 employees
Revenue 2019
SEK 0
EBITDA margin
—
-400% vs 2018
Equity ratio
—
Financial strength
Net profit 2019
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -50K | -400% |
| Net profit | SEK 0 | — |
| Total assets | SEK 0 | -100% |
| Equity | SEK 120K | +140% |
| Employees | 0 | — |
Legal name
Hemfosa NYAB 18 AB
Org number
5591685994
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
21 augusti 2018
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Bolaget skall, direkt eller indirekt, äga och förvalta fastigheter samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −10 | −50 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −10 | −50 |
| Net financials | — | — |
| Profit before tax | 0 | 0 |
| Tax | −0 | −0 |
| Net profit | 0 | 0 |
| Item | 2018 | 2019 |
|---|---|---|
| Total assets | 61 | 0 |
| Equity | 50 | 120 |
| Long-term debt | 0 | 0 |
| Short-term debt | 11 | −120 |
| Total debt | 11 | −120 |
EBITDA margin
-5000000.0%
This company
15.8%
Market median
-31645670% vs market
20182019
Equity ratio
12000000.0%
This company
38.2%
Market median
+31413513% vs market
20182019
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20182019
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20182019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182019
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20182019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-08-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
AM External Signatory | External Signatory | 2020 – 2020 |
AE External Signatory | External Signatory | 2020 – 2020 |
LE External Signatory | External Signatory | 2020 – 2020 |
JS External Signatory | External Signatory | 2020 – 2020 |
JM Chief Auditor | Chief Auditor | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2020 – 2020 | |
| Chairman | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2020 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hemfosa NYAB 18 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Maria Alsborger | External Signatory | 0 companies |
| Annika Elisabeth Ekström | External Signatory | 0 companies |
| Linda Elisabeth Eriksson | External Signatory | 0 companies |
| Johanna Stina Maria Bjärnemyr | External Signatory | 0 companies |
| Johanna Maria Hagström Jerkeryd | Chief Auditor | 0 companies |
| Sofia Eva-Lotta Strid | Board of Directors | 0 companies |
| Caroline Arehult | Board of Directors | 0 companies |
| Ilija Batljan | Chairman | 0 companies |
| Hans Peter Anderson | Deputy Board Member | 0 companies |
| Oscar Sven Lekander | Board of Directors | 0 companies |